Literature DB >> 30021780

TCF1 expression marks self-renewing human CD8+ T cells.

Radomir Kratchmarov1,2, Arthur M Magun3, Steven L Reiner1,2.   

Abstract

Expression of the transcription factor T-cell factor 1 (TCF1) identifies antigen-experienced murine CD8+ T cells that retain potential for lymphoid recirculation and the ability to self-renew while producing more differentiated effector cells. We found that CD8+ T cells in the blood of both healthy and chronically infected humans expressed TCF1 at 3 distinct levels: high (TCF1-hi), intermediate (TCF1-int), and low (TCF1-lo). TCF1-hi cells could be found within both the naive and memory compartments and were characterized by relative quiescence and lack of immediate effector function. A substantial fraction of TCF1-int cells were found among memory cells, and TCF1-int cells exhibited robust immediate effector functions. TCF1-lo cells were most enriched in effector memory cells that expressed the senescence marker CD57. Following reactivation, TCF1-hi cells gave rise to TCF1-lo descendants while self-renewing the TCF1-hi progenitor. By contrast, reactivation of TCF1-lo cells produced more TCF1-lo cells without evidence of de-differentiating into TCF1-hi cells. Flow cytometric analyses of TCF1 expression from patient specimens may become a useful biomarker for adaptive immune function in response to vaccination, infection, autoimmunity, and cancer.
© 2018 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30021780      PMCID: PMC6058237          DOI: 10.1182/bloodadvances.2018016279

Source DB:  PubMed          Journal:  Blood Adv        ISSN: 2473-9529


  20 in total

Review 1.  The who's who of T-cell differentiation: human memory T-cell subsets.

Authors:  Yolanda D Mahnke; Tess M Brodie; Federica Sallusto; Mario Roederer; Enrico Lugli
Journal:  Eur J Immunol       Date:  2013-10-30       Impact factor: 5.532

2.  Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells.

Authors:  Jason M Brenchley; Nitin J Karandikar; Michael R Betts; David R Ambrozak; Brenna J Hill; Laura E Crotty; Joseph P Casazza; Janaki Kuruppu; Stephen A Migueles; Mark Connors; Mario Roederer; Daniel C Douek; Richard A Koup
Journal:  Blood       Date:  2002-11-14       Impact factor: 22.113

3.  Asymmetric PI3K Signaling Driving Developmental and Regenerative Cell Fate Bifurcation.

Authors:  Wen-Hsuan W Lin; William C Adams; Simone A Nish; Yen-Hua Chen; Bonnie Yen; Nyanza J Rothman; Radomir Kratchmarov; Takaharu Okada; Ulf Klein; Steven L Reiner
Journal:  Cell Rep       Date:  2015-11-25       Impact factor: 9.423

4.  T-cell invigoration to tumour burden ratio associated with anti-PD-1 response.

Authors:  Alexander C Huang; Michael A Postow; Robert J Orlowski; Rosemarie Mick; Bertram Bengsch; Sasikanth Manne; Wei Xu; Shannon Harmon; Josephine R Giles; Brandon Wenz; Matthew Adamow; Deborah Kuk; Katherine S Panageas; Cristina Carrera; Phillip Wong; Felix Quagliarello; Bradley Wubbenhorst; Kurt D'Andrea; Kristen E Pauken; Ramin S Herati; Ryan P Staupe; Jason M Schenkel; Suzanne McGettigan; Shawn Kothari; Sangeeth M George; Robert H Vonderheide; Ravi K Amaravadi; Giorgos C Karakousis; Lynn M Schuchter; Xiaowei Xu; Katherine L Nathanson; Jedd D Wolchok; Tara C Gangadhar; E John Wherry
Journal:  Nature       Date:  2017-04-10       Impact factor: 49.962

5.  CD8+ T Lymphocyte Self-Renewal during Effector Cell Determination.

Authors:  Wen-Hsuan W Lin; Simone A Nish; Bonnie Yen; Yen-Hua Chen; William C Adams; Radomir Kratchmarov; Nyanza J Rothman; Avinash Bhandoola; Hai-Hui Xue; Steven L Reiner
Journal:  Cell Rep       Date:  2016-11-08       Impact factor: 9.423

6.  Control of effector CD8+ T cell function by the transcription factor Eomesodermin.

Authors:  Erika L Pearce; Alan C Mullen; Gislâine A Martins; Connie M Krawczyk; Anne S Hutchins; Valerie P Zediak; Monica Banica; Catherine B DiCioccio; Darrick A Gross; Chai-An Mao; Hao Shen; Nezih Cereb; Soo Y Yang; Tullia Lindsten; Janet Rossant; Christopher A Hunter; Steven L Reiner
Journal:  Science       Date:  2003-11-07       Impact factor: 47.728

7.  Bystander chronic infection negatively impacts development of CD8(+) T cell memory.

Authors:  Erietta Stelekati; Haina Shin; Travis A Doering; Douglas V Dolfi; Carly G Ziegler; Daniel P Beiting; Lucas Dawson; Jennifer Liboon; David Wolski; Mohammed-Alkhatim A Ali; Peter D Katsikis; Hao Shen; David S Roos; W Nicholas Haining; Georg M Lauer; E John Wherry
Journal:  Immunity       Date:  2014-05-15       Impact factor: 31.745

8.  T-cell factor 1 is a gatekeeper for T-cell specification in response to Notch signaling.

Authors:  Kristine Germar; Marei Dose; Tassos Konstantinou; Jiangwen Zhang; Hongfang Wang; Camille Lobry; Kelly L Arnett; Stephen C Blacklow; Iannis Aifantis; Jon C Aster; Fotini Gounari
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-22       Impact factor: 11.205

9.  Human naive CD8 T cells down-regulate expression of the WNT pathway transcription factors lymphoid enhancer binding factor 1 and transcription factor 7 (T cell factor-1) following antigen encounter in vitro and in vivo.

Authors:  Tim Willinger; Tom Freeman; Mark Herbert; Hitoshi Hasegawa; Andrew J McMichael; Margaret F C Callan
Journal:  J Immunol       Date:  2006-02-01       Impact factor: 5.422

10.  Continuous activity of Foxo1 is required to prevent anergy and maintain the memory state of CD8+ T cells.

Authors:  Arnaud Delpoux; Rodrigo Hess Michelini; Shilpi Verma; Chen-Yen Lai; Kyla D Omilusik; Daniel T Utzschneider; Alec J Redwood; Ananda W Goldrath; Chris A Benedict; Stephen M Hedrick
Journal:  J Exp Med       Date:  2017-12-27       Impact factor: 14.307

View more
  39 in total

1.  Early alterations in stem-like/resident T cells, innate and myeloid cells in the bone marrow in preneoplastic gammopathy.

Authors:  Jithendra Kini Bailur; Samuel S McCachren; Deon B Doxie; Mahesh Shrestha; Katherine Pendleton; Ajay K Nooka; Natalia Neparidze; Terri L Parker; Noffar Bar; Jonathan L Kaufman; Craig C Hofmeister; Lawrence H Boise; Sagar Lonial; Melissa L Kemp; Kavita M Dhodapkar; Madhav V Dhodapkar
Journal:  JCI Insight       Date:  2019-04-23

2.  PD-L1 Checkpoint Inhibition Narrows the Antigen-Specific T Cell Receptor Repertoire in Chronic Lymphocytic Choriomeningitis Virus Infection.

Authors:  S Klein; D Ghersi; M P Manns; I Prinz; M Cornberg; A R M Kraft
Journal:  J Virol       Date:  2020-08-31       Impact factor: 5.103

Review 3.  Rethinking peripheral T cell tolerance: checkpoints across a T cell's journey.

Authors:  Mohamed A ElTanbouly; Randolph J Noelle
Journal:  Nat Rev Immunol       Date:  2020-10-19       Impact factor: 53.106

Review 4.  Biomarkers Predictive of Survival and Response to Immune Checkpoint Inhibitors in Melanoma.

Authors:  Emanuelle M Rizk; Angelina M Seffens; Megan H Trager; Michael R Moore; Larisa J Geskin; Robyn D Gartrell-Corrado; Winston Wong; Yvonne M Saenger
Journal:  Am J Clin Dermatol       Date:  2020-02       Impact factor: 7.403

Review 5.  Stem, Effector, and Hybrid States of Memory CD8+ T Cells.

Authors:  Enrico Lugli; Giovanni Galletti; Shannon K Boi; Benjamin A Youngblood
Journal:  Trends Immunol       Date:  2019-12-04       Impact factor: 16.687

6.  Immunological history governs human stem cell memory CD4 heterogeneity via the Wnt signaling pathway.

Authors:  Hassen Kared; Shu Wen Tan; Mai Chan Lau; Marion Chevrier; Crystal Tan; Wilson How; Glenn Wong; Marie Strickland; Benoit Malleret; Amanda Amoah; Karolina Pilipow; Veronica Zanon; Naomi Mc Govern; Josephine Lum; Jin Miao Chen; Bernett Lee; Maria Carolina Florian; Hartmut Geiger; Florent Ginhoux; Ezequiel Ruiz-Mateos; Tamas Fulop; Reena Rajasuriar; Adeeba Kamarulzaman; Tze Pin Ng; Enrico Lugli; Anis Larbi
Journal:  Nat Commun       Date:  2020-02-10       Impact factor: 14.919

Review 7.  TCF1 in T cell immunity: a broadened frontier.

Authors:  Xudong Zhao; Qiang Shan; Hai-Hui Xue
Journal:  Nat Rev Immunol       Date:  2021-06-14       Impact factor: 53.106

Review 8.  A key control point in the T cell response to chronic infection and neoplasia: FOXO1.

Authors:  Nimi Marcel; Stephen M Hedrick
Journal:  Curr Opin Immunol       Date:  2020-03-02       Impact factor: 7.486

9.  Immune Activation Induces Telomeric DNA Damage and Promotes Short-Lived Effector T Cell Differentiation in Chronic HCV Infection.

Authors:  Lam Nhat Nguyen; Lam Ngoc Thao Nguyen; Juan Zhao; Madison Schank; Xindi Dang; Dechao Cao; Sushant Khanal; Bal Krishna Chand Thakuri; Jinyu Zhang; Zeyuan Lu; Xiao Y Wu; Mohamed El Gazzar; Shunbin Ning; Ling Wang; Jonathan P Moorman; Zhi Q Yao
Journal:  Hepatology       Date:  2021-08-25       Impact factor: 17.425

10.  Increased frequency of TIGIT+CD73-CD8+ T cells with a TOX+ TCF-1low profile in patients with newly diagnosed and relapsed AML.

Authors:  F Brauneck; F Haag; R Woost; N Wildner; E Tolosa; A Rissiek; G Vohwinkel; J Wellbrock; C Bokemeyer; J Schulze Zur Wiesch; C Ackermann; W Fiedler
Journal:  Oncoimmunology       Date:  2021-06-21       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.